| Execution period | 5 years |
|---|
BSE filing, BSE: 541444. Summary written from the filing by ALFA Finder's alert engine.
Palm Jewels Ltd: key numbers
- Share price
- ₹27.79
- Market cap
- ₹27.90 Cr
- Revenue (annual)
- ₹185.3 Cr
- Net profit (annual)
- ₹1.00 Cr
- P/E (TTM)
- 29.2×Sector 49.5×
- Promoter holding
- 43.36%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Palm Jewels Ltd
All →Palm Jewels Board Meeting Date
Palm Jewels will hold a board meeting on 30 October 2026 to consider unaudited quarterly results. The trading window reopens on 3 November 2026.
Palm Jewels Price Movement Clarification
Palm Jewels Limited clarified that recent share price movements are purely market-driven, confirming no pending price-sensitive information or announcements were withheld from the exchanges.
Palm Jewels Other Announcement
Palm Jewels Limited filed its quarterly Regulation 74(5) compliance certificate from its Registrar, KFin Technologies, for the period ending September 30, 2026.
Palm Jewels Annual General Meeting
Palm Jewels Ltd held its 21st Annual General Meeting on September 29, 2026. The meeting transacted ordinary business items as detailed in the AGM notice.
Palm Jewels Annual General Meeting
Palm Jewels Ltd has issued a notice for its Annual General Meeting scheduled for September 29, 2026. The agenda includes financial statements and director re-appointment.
Palm Jewels Annual Report
Palm Jewels Limited has submitted its Annual Report for the financial year 2025-26. The company also announced its Annual General Meeting scheduled for September 29, 2026.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.